Product Categories
| Country: | China |
|---|---|
| Tel: | 025-846993838003 |
| Mobile: | 18013301590 |
| E-mail: | njduly@126.com |
| QQ: | 1300427959 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Bryostatin 1 | C47H68O17 | 83314-01-6 | Details |
| BVT 948 | C14H11NO3 | 39674-97-0 | Details |
| BPTES | C24H24N6O2S3 | 314045-39-1 | Details |
| BRD-7389 | C24H18N2O2 | 376382-11-5 | Details |
| BMH 21 | C21H20N4O2 | 896705-16-1 | Details |
| B02 | C22H17N3O | 1290541-46-6 | Details |
| CGK 733 | C23H18Cl3FN4O3S | 905973-89-9 | Details |
| Cinaciguat | C36H39NO5 | 329773-35-5 | Details |
| CX-6258 | C26H24ClN3O3 | 1202916-90-2 | Details |
| Cathepsin Inhibitor 1 | C20H24ClN5O2 | 225120-65-0 | Details |
| Coenzyme A, Trilithium salt, Hydrate | C21H37LiN7O16P3S | 18439-24-2 | Details |
| CZC24832 | C15H17FN6O2S | 1159824-67-5 | Details |
| Calcineurin Substrate | C92H150N28O29 | 113873-67-9 | Details |
| BAY 41-2272 | C20H17FN6 | 256376-24-6 | Details |
| BMS 566419 | C28H30FN5O2 | 566161-24-8 | Details |
| CCF 642 | C15H10N2O4S3 | 346640-08-2 | Details |
| Chymotrypsin Substrate II, Fluorogenic | C34H39N5O9 | 88467-45-2 | Details |
| BMS 303141 | C19H15Cl2NO4S | 943962-47-8 | Details |
| CPI-1205 | C27H33F3N4O3 | 1621862-70-1 | Details |
| 680C91 | C15H11FN2 | 163239-22-3 | Details |
| C3 | C23H34N4O | 1268709-57-4 | Details |
| Cathepsin G substrate | C27H38N6O9S | 70967-91-8 | Details |
| CP 316819 | C21H22ClN3O4 | 186392-43-8 | Details |
| Balicatib | C23H33N5O2 | 354813-19-7 | Details |
| Cathepsin G Inhibitor | C36H33N2O6P | 429676-93-7 | Details |
| BC-LI-0186 | C22H27N3O4S | 695207-56-8 | Details |
| BRD 73954 | C16H16N2O3 | 1440209-96-0 | Details |
| CycLuc 1 | C13H11N3O2S2 | 1247879-16-8 | Details |
| coenzyme B12 | C72H99CoN18O17P | 13870-90-1 | Details |
| Cytochrome P450 14a-demethylase inhibitor 1A | C21H22F2N4O | 1155360-99-8 | Details |
| Diisopropyl-fluorophosphatase | 9032-18-2 | Details |
| Elvitegravir (GS-9137, JTK-303) | C23H23ClFNO5 | 697761-98-1 | Details |
| Diprotin B | C16H29N3O4 | 90614-49-6 | Details |
| JW55 | C25H26N2O5 | 664993-53-7 | Details |
| ER 27319 maleate | C22H24N2O5 | 1204480-26-1 | Details |
| JZP 430 | C16H26N4O3S | 1672691-74-5 | Details |
| KN-93 | C26H29ClN2O4S | 139298-40-1 | Details |
| RON Dual Kinase Inhibitor inhibitor | C31H29FN4O5 | 913376-84-8 | Details |
| EPZ015866 (GSK591) | C22H28N4O2 | 1616391-87-7 | Details |
| DAPT | C23H26F2N2O4 | 208255-80-5 | Details |
| E-64 | C15H27N5O5 | 66701-25-5 | Details |
| casein kinase I Substrate（TFA) | C85H139N27O35S | 154444-97-0 | Details |
| CEP-18770 (Delanzomib) | C21H28BN3O5 | 847499-27-8 | Details |
| Histone Acetyltransferase Inhibitor II | C20H16Br2O3 | 932749-62-7 | Details |
| JFD01307SC | C6H11NO4S | 51070-56-5 | Details |
| JW 480 | C22H23NO2 | 1354359-53-7 | Details |
| Heclin | C17H17NO3 | 890605-54-6 | Details |
| Ki8751 | C24H18F3N3O4 | 228559-41-9 | Details |
| GSK 2830371 | C23H29ClN4O2S | 1404456-53-6 | Details |
| e-6005 | C26H24N4O5 | 947620-48-6 | Details |
| Disodium 1-Naphthyl Phosphate Hydrate [Substrate for Phosphatase | C10H12NaO5P | 207569-06-0 | Details |
| E-64d | C17H30N2O5 | 88321-09-9 | Details |
| FG-4592 | C19H16N2O5 | 808118-40-3 | Details |
| GTP 14564 | C15H10N2O | 34823-86-4 | Details |
| DuP 697 | C17H12BrFO2S2 | 88149-94-4 | Details |
| KN-62 | C38H35N5O6S2 | 127191-97-3 | Details |
| DCLK1-IN-1 | C26H28F3N7O2 | 2222635-15-4 | Details |
| E 2012 | C25H26FN3O2 | 870843-42-8 | Details |
| docosahexaenoyl Coenzyme A (ammonium salt) | C43H69N8O17P3S | 800377-20-2 | Details |
| DiFMUP | C10H7F2O6P | 214491-43-7 | Details |
| Cathepsin G Substrate | C30H36N6O9 | 70967-97-4 | Details |
| H 89 2HCl | C20H20BrN3O2S.2ClH.H2O | 130964-39-5 | Details |
| GW5074 | C15H8Br2INO2 | 220904-83-6 | Details |
| LY2157299 | C22H19N5O | 700874-72-2 | Details |
| GS 441524 | C12H13N5O4 | 1191237-69-0 | Details |
| LY2811376 | C15H14F2N4S | 1194044-20-6 | Details |
| LRRK2-IN-1 | C31H38N8O3 | 1234480-84-2 | Details |
| GW441756 | C17H13N3O | 504433-23-2 | Details |
| IKK-16 (hydrochloride) | C28H31ClN6OS | 1186195-62-9 | Details |
| IOX2 | C19H16N2O5 | 931398-72-0 | Details |
| KYP 2047 | C20H25N3O2 | 796874-99-2 | Details |
| K252b | C26H19N3O5 | 99570-78-2 | Details |
| HI TOPK 032 | C20H11N5OS | 487020-03-1 | Details |
| GNF-2 | C18H13F3N4O2 | 778270-11-4 | Details |
| FMK | C18H19FN4O2 | 821794-92-7 | Details |
| KU-60019 | C30H33N3O5S | 925701-49-1 | Details |
| GSK 650394 | C25H22N2O2 | 890842-28-1 | Details |
| JIB-04 | C17H13ClN4 | 199596-05-9 | Details |
| GSK343 | C31H39N7O2 | 1346704-33-3 | Details |
| 5(6)-FITC DA | C26H19NO7S | 871487-69-3 | Details |
| GGsTop | C13H18NO7P | 926281-37-0 | Details |
| OSI-906 (Linsitinib) | C26H23N5O | 867160-71-2 | Details |
| GSK1059615 | C18H11N3O2S | 958852-01-2 | Details |
| GSK-J4 | C24H27N5O2 | 1373423-53-0 | Details |
| KH 7 | C17H15BrN4O2S | 330676-02-3 | Details |
| KW-2449 | C20H20N4O | 1000669-72-6 | Details |
| GSK126 | C31H38N6O2 | 1346574-57-9 | Details |
| GSK-J1 | C22H23N5O2 | 1373422-53-7 | Details |
| GSK503 | C31H38N6O2 | 1346572-63-1 | Details |
| GSK-356278 | C21H25N7O2S | 720704-34-7 | Details |
| INF 4E | C12H13ClO3 | 88039-46-7 | Details |
| GI254023X | C21H33N3O4 | 260264-93-5 | Details |
| KU-55933 (ATM Kinase Inhibitor) | C21H17NO3S2 | 587871-26-9 | Details |
| FK 3311 | C15H13F2NO4S | 116686-15-8 | Details |
| GSK-690693 | C21H27N7O3 | 937174-76-0 | Details |
| GSK1904529A | C44H47F2N9O5S | 1089283-49-7 | Details |
| GSK2126458 (GSK458) | C25H17F2N5O3S | 1086062-66-9 | Details |
| LY2801653 | C30H22F2N6O3 | 1206799-15-6 | Details |
| K-252a | C27H21N3O5 | 99533-80-9 | Details |
| Z-FA-FMK | C21H23FN2O4 | 105637-38-5 | Details |
| Product Total： Product Page： | ||||
| 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 | ||||